有価証券レコード · アーカイブ済み四半期
EOLS
Evolus, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
17追跡対象保有者
-1Δ保有者数
17.27M保有株数
$106.03M報告済み評価額
+0新規ポジション
−1解消銘柄
モメンタム指標（同類マネージャー）：
保有者の広がり -5.6% ·
株式フロー +9.7% ·
新規ネットポジション数 -5.9%
— 計算式
集中的な買い集め — 保有者数が減少する中で株式数が増加
すべての保有状況データ：追跡対象13Fマネージャーのみ、普通株ポジション、報告期間 Q3 2025
保有状況の推移
| 四半期 | 保有者 | Δ | 株数 | 報告済み評価額 | 新規 | 解消銘柄 |
|---|---|---|---|---|---|---|
| Q2 2026 | 63 | +6 | 23.25M | $161.16M | +10 | −4 |
| Q1 2026 | 59 | -7 | 18.93M | $77.97M | +3 | −10 |
| Q4 2025 | 66 | -1 | 24.04M | $159.85M | — | −1 |
| Q3 2025 | 17 | -1 | 17.27M | $106.03M | — | −1 |
| Q2 2025 | 15 | 0 | 14.12M | $130.04M | +1 | −1 |
| Q1 2025 | 12 | +2 | 7.19M | $86.49M | +2 | — |
| Q4 2024 | 10 | -1 | 6.42M | $70.90M | — | −1 |
| Q3 2024 | 10 | 0 | 4.64M | $75.21M | +1 | −1 |
| Q2 2024 | 10 | — | 4.38M | $47.51M | — | — |
保有者情報 · Q3 2025
| # | 運用会社 | 株数 | Δ株式数 | 時価 | そのウェイト | 保有中 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (パッシブ) | 4.48M | +7.0% | $27.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (パッシブ) | 4.48M | +7.0% | $27.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (パッシブ) | 4.48M | +7.0% | $27.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (パッシブ) | 4.48M | +7.0% | $27.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (パッシブ) | 4.48M | +7.0% | $27.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (パッシブ) | 4.48M | +7.0% | $27.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (パッシブ) | 4.48M | +7.0% | $27.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (パッシブ) | 4.48M | +7.0% | $27.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (パッシブ) | 4.48M | +7.0% | $27.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (パッシブ) | 4.48M | +7.0% | $27.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (パッシブ) | 4.48M | +7.0% | $27.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (パッシブ) | 3.43M | +3.3% | $21.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (パッシブ) | 3.43M | +3.3% | $21.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (パッシブ) | 3.43M | +3.3% | $21.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (パッシブ) | 3.43M | +3.3% | $21.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (パッシブ) | 3.43M | +3.3% | $21.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Millennium Management ✦ | 1.86M | +25.3% | $11.41M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (パッシブ) | 1.52M | +7.7% | $9.30M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Geode Capital Management ✦ (パッシブ) | 1.42M | +15.1% | $8.70M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Geode Capital Management ✦ (パッシブ) | 1.42M | +15.1% | $8.70M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 1.35M | +41.4% | $8.32M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 1.35M | +41.4% | $8.32M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 892.62K | — | $5.48M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 892.62K | — | $5.48M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 892.62K | — | $5.48M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 892.62K | — | $5.48M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 892.62K | — | $5.48M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 892.62K | — | $5.48M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 892.62K | — | $5.48M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 892.62K | — | $5.48M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 892.62K | — | $5.48M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 892.62K | — | $5.48M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Renaissance Technologies ✦ | 626.00K | +83.4% | $3.84M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 588.41K | +1.1% | $3.61M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 35 | Citadel Advisors ✦ | 588.41K | +1.1% | $3.61M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 36 | Goldman Sachs Group ✦ | 457.70K | — | $2.81M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Goldman Sachs Group ✦ | 457.70K | — | $2.81M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Morgan Stanley ✦ | 265.73K | — | $1.63M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Morgan Stanley ✦ | 265.73K | — | $1.63M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Morgan Stanley ✦ | 265.73K | — | $1.63M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Morgan Stanley ✦ | 265.73K | — | $1.63M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Morgan Stanley ✦ | 265.73K | — | $1.63M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | Morgan Stanley ✦ | 265.73K | — | $1.63M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | Morgan Stanley ✦ | 265.73K | — | $1.63M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Wellington Management ✦ | 184.31K | +12.4% | $1.13M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 46 | Wellington Management ✦ | 184.31K | +12.4% | $1.13M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 47 | Wellington Management ✦ | 184.31K | +12.4% | $1.13M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 48 | T. Rowe Price ✦ | 63.34K | +12.4% | $389,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 58.34K | -18.1% | $358,226 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 50 | Marshall Wace ✦ | 56.59K | -16.6% | $347,451 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 51 | Marshall Wace ✦ | 56.59K | -16.6% | $347,451 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 52 | Two Sigma Investments ✦ | 19.77K | -84.0% | $121,382 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 53 | Fidelity (FMR) ✦ | 4.35K | +80.2% | $26,718 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 54 | Fidelity (FMR) ✦ | 4.35K | +80.2% | $26,718 | 0.0% | ▲ Add | 2 | SEC ↗ |
「当該ウェイト」= そのマネージャーの報告済み13F株式評価額に占めるポジションの割合（確信度の指標）。✦ = キュレーション済みマネージャー。
新規買い手
| 今四半期は新規追跡買い手がいません。 |
ポジション解消済み
| Adage Capital Partners | $1.18M | だった 0.0% |
市場全体のコンテキスト: 全13Fファイラー対象（SEC構造化データ、 Q1 2026): 146 保有者, 45.63M 株式数, $187.01M 報告済み. これは上記の追跡対象ユニバースの数値とは異なる、より古い期間のものであり、両者が混在することはありません。
共同保有が多い銘柄
この有価証券の追跡対象保有者が最も頻繁に保有する他の銘柄 — ファンダメンタルな関係ではなく、共同保有件数に基づきます。